GRAFT-VERSUS-HOST DISEASE

[1] THYMUS TRANSPLANTATION AFTER ALLOGENEIC BONE-MARROW GRAFT TO PREVENT CHRONIC GRAFT VERSUS HOST-DISEASE IN HUMANS [J]. TRANSPLANTATION, 1982, 33 (02) : 168 - 173

[2] BARRETT A, 1979, RADIOLOGY, V133, P587

[3] CHRONIC GRAFT VERSUS HOST-DISEASE IN THE RAT RADIATION CHIMERA .1. CLINICAL-FEATURES, HEMATOLOGY, HISTOLOGY, AND IMMUNOPATHOLOGY IN LONG-TERM CHIMERAS [J]. TRANSPLANTATION, 1982, 33 (04) : 393 - 399

[4] LYMPHOCYTIC BRONCHITIS ASSOCIATED WITH GRAFT VERSUS HOST DISEASE IN RECIPIENTS OF BONE-MARROW TRANSPLANTS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (19) : 1030 - 1036

[5] BIGGS J, 1985, EXP HEMATOL, V13, P324

[6] GRAFT VERSUS LEUKEMIA .3. APPARENT INDEPENDENT ANTIHOST AND ANTILEUKEMIC ACTIVITY OF TRANSPLANTED IMMUNOCOMPETENT CELLS [J]. TRANSPLANTATION, 1973, 16 (03) : 182 - 188

[7] GRAFT VERSUS LEUKEMIA .5. ABSENCE OF ANTILEUKEMIC EFFECT USING ALLOGENEIC H-2-IDENTICAL IMMUNOCOMPETENT CELLS [J]. TRANSPLANTATION, 1974, 18 (03) : 280 - 283

[8] BORTIN MM, 1985, EXP HEMATOL, V13, P406

[9] BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA - FACTORS ASSOCIATED WITH EARLY MORTALITY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (09): : 1166 - 1175

[10] SEVERE COMBINED IMMUNODEFICIENCY DISEASE - CHARACTERIZATION OF DISEASE AND RESULTS OF TRANSPLANTATION [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 238 (07): : 591 - 600

[1] THYMUS TRANSPLANTATION AFTER ALLOGENEIC BONE-MARROW GRAFT TO PREVENT CHRONIC GRAFT VERSUS HOST-DISEASE IN HUMANS [J]. TRANSPLANTATION, 1982, 33 (02) : 168 - 173

[2] BARRETT A, 1979, RADIOLOGY, V133, P587

[3] CHRONIC GRAFT VERSUS HOST-DISEASE IN THE RAT RADIATION CHIMERA .1. CLINICAL-FEATURES, HEMATOLOGY, HISTOLOGY, AND IMMUNOPATHOLOGY IN LONG-TERM CHIMERAS [J]. TRANSPLANTATION, 1982, 33 (04) : 393 - 399

[4] LYMPHOCYTIC BRONCHITIS ASSOCIATED WITH GRAFT VERSUS HOST DISEASE IN RECIPIENTS OF BONE-MARROW TRANSPLANTS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (19) : 1030 - 1036

[5] BIGGS J, 1985, EXP HEMATOL, V13, P324

[6] GRAFT VERSUS LEUKEMIA .3. APPARENT INDEPENDENT ANTIHOST AND ANTILEUKEMIC ACTIVITY OF TRANSPLANTED IMMUNOCOMPETENT CELLS [J]. TRANSPLANTATION, 1973, 16 (03) : 182 - 188

[7] GRAFT VERSUS LEUKEMIA .5. ABSENCE OF ANTILEUKEMIC EFFECT USING ALLOGENEIC H-2-IDENTICAL IMMUNOCOMPETENT CELLS [J]. TRANSPLANTATION, 1974, 18 (03) : 280 - 283

[8] BORTIN MM, 1985, EXP HEMATOL, V13, P406

[9] BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA - FACTORS ASSOCIATED WITH EARLY MORTALITY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (09): : 1166 - 1175

[10] SEVERE COMBINED IMMUNODEFICIENCY DISEASE - CHARACTERIZATION OF DISEASE AND RESULTS OF TRANSPLANTATION [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 238 (07): : 591 - 600